The fine structure and types of contact made by GABAergic elements in the septal nuclei were studied at the electron- The inhibitory amino acid y-aminobutyric acid (GABA) represents a substantial proportion of the transmitters present in the septal region (Walaas and Fonnum, 1979) . Immunohistochemistry using anti-GABA antibodies has provided descriptions of the regional distribution of GABA-immunoreactive elements in the rat septum (Ottersen and Storm-Mathisen, 1984; OntCniente et al., 1986 ) that correlate previous studies per-formed with antibodies directed against the GABA-synthesizing enzyme L-glutamate decarboxylase (GAD) (Costa et al., 1983; Kijhler and Chan-Palay, 1983; Panula et al., 1984) . In the lateral septal nucleus, randomly distributed cell bodies were described as part of an important network of GABA-containing axonal varicosities, while the medial part contained mostly GABAergic cells among the myelinated fiber tracts. Physiological data (De France, 1976) , supported by anatomical differences (Panula et al., 1984; Onttniente et al., 1986) , suggested the existence of 2 functionally distinct GABAergic systems in the lateral and medial septal nuclei.
The functional significance of GABA within the septum is probably related to its general inhibitory action. Electrophysiological studies showed the involvement of GABA in the control of electrical activity in the septohippocampal axis (McLennan and Miller, 1974) . Different roles in endocrine regulation via the septohypothalamic route have also been evidenced (De Feudis, 1984) . However, ultrastructural studies giving morphological support to such interactions of GABAergic elements with other components of the septal area are lacking.
This study aimed at determining, by means of peroxidase immunocytochemistry applied to anti-GABA antibodies, the ultrastructural features and types of contact displayed by GABAcontaining structures in the lateral and medial septal nuclei.
Materials and Methods
Twenty male adult Wistar rats weighing 200 gm were used. Twentyfour hours before they were killed, 10 animals received, under pentobarbital anaesthesia (35 mg/kg), an injection of 10 pg colchicine (Sigma) in 1 ~1 saline solution into the frontal part of the medial septum at the "Bregma 1 mm" level of the atlas of Paxinos and Watson (1982) . After fresh anaesthesia, normal and colchicine-injected rats were perfused via the ascending aorta by an ice-cold mixture of 5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2. Brains were removed, the septal region dissected out and immersed in the same fixative for an additional 45 min. Vibratome sections, 50 pm thick, were cut and washed for 1 hr in 0.1 M Tris buffer, pH 7.2 GABA antibodies (Seguela et al., 1984) were used at a dilution of 1: 4000 in the same buffer for an overnight incubation at 4°C. After 30 min of washing, the sections were incubated in peroxidase-labeled Fab fragments of anti-rabbit IaG ( 1: 1000: Biosvs) for 1 hr at room temner- Immunocytochemical controls were performed on sections of both colchicine-treated and normal animals by incubation in normal rabbit serum or in primary antiserum previously adsorbed by its immunogen.
After observation of the immunocytochemical reaction under the light microscope, the sections were postfixed in 1% osmium tetroxide for 1 hr, dehydrated, and flat-embedded in Epon 8 12. After polymerization, they were again observed under the light microscope, pieces of interest were cut off and attached to Epon supports for ultrathin sectioning on Bar, 0.6 pm. F, A contact (arrow) between a Reichert OmU2 ultramicrotome. Ultrathin sections were contrasted with uranyl acetate and lead citrate and observed on a Philips 300 electron microscope.
Results

General characteristics of GABA-immunolabeling
In the Vibratome sections observed under a light microscope, GABA-immunoreactive (GABA-I) elements included nerve cell bodies, with their proximal dendrites and punctate profiles overlying the whole septum. Punctate profiles were frequently seen on GABA-I neurons. Control sections were completely devoid of immunoreaction.
Topical injections of colchicine revealed an additional group of GABA-I neurons of large size (30 pm) in the medial septum.
Ultrathin sections of the lateral septum showed GABA-immunoreaction within medium-sized (10-20 pm) somata (Fig.  1A) and dendrites (Fig. ID) , synaptic boutons (Fig. lc) , and small unmyelinated axons (Fig. 1B) . In addition, large GABA-I cells ( Fig. 3E ) and myelinated axons (Fig. 1E ) were found in the medial septum. The general distribution pattern of the immunoreaction was similar within the 2 populations of cells (Figs. 1A and 3A) : diffuse in the cytoplasm, occasionally present in the nucleus, with no precise relationship with cytoplasmic organelles, and associated with the external side of their membrane.
Punctate profiles observed in the light microscope were shown by electron microscopy to be axonal boutons, terminals, or cross sections of small dendrites. The density of GABA-I dendrites was much higher than that of GABA-I synaptic boutons, which were labeled only within a depth of 5 pm in the sections. As a counterpart, synaptic boutons displayed a more intense labeling than adjacent dendrites and cell bodies. GABA-I axonal varicosities contained round synaptic vesicles with varying internal electron densities which were very rarely immunolabeled (Fig.  2G) . The peroxidase product was found in the cytoplasm between the vesicles, linked to the outer surface of vesicular and mitochondrial membranes, and within aggregates at synaptic sites. Large, granulated vesicles of 60-80 nm were occasionally observed within GABA-I boutons, with no internal immunoreactivity (Fig. 1 C) .
Synaptic organization
The large GABA-I neurons of the medial septum received a greater number of synapses than did the smaller ones. Four types of presynaptic elements were observed: (1) non-GABA-I terminals with small synaptic vesicles (Fig. 2, A, B, E, F, Fig. 3 , B, C, E); (2) non-GABA-I terminals with small synaptic vesicles and large granular (60-80 nm) vesicles, with varying electron densities (Fig. 2, B, D) ; (3) GABA-I terminals with synaptic vesicles, some of which were occasionally labeled (Fig. 2, C-G;  Fig. 3, A, B, D) ; and (4) GABA-I terminals with large clear vesicles (Fig. 1 C) . The third type of synapse could be observed on somatic spines (Fig. 2E) .
Synapses on GABA-I cell bodies and dendrites were generally asymmetrical, with a strong postsynaptic thickening, while symmetrical ones were observed more rarely (Fig. 2, C, D; Fig. 3 
, B, E). Dense accumulations of immunoreaction end product at t
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, A, B, E).
In rare cases, GABA-I boutons in contact with unlabeled terminals making synapses with GABA-I somata (Fig. 2F) were observed.The lack of postsynaptic thickening in symmetrical synapses made it difficult to assess whether such axoaxonic contacts were synapses. However, they presented electron-dense material between the 2 membranes concerned and an accumulation of vesicles close to the site of contact.
Discussion
Distribution of GABA-immunoreactivity Previous biochemical (Seguela et al., 1984) and immunocytochemical (Seguela et al., 1985; Gamrani et al., 1986 ) studies have established the specificity of the GABA antibody for the detection of GABA within the rat CNS. The distribution of immunoreactive elements was similar to that observed with other antibodies directed against GAD (Costa et al., 1983; Kohler and Chan-Palay, 1983; Panula et al., 1984) and GABA (Ottersen and Storm-Mathisen, 1984; Onteniente et al., 1986 ). The ultrastructural distribution of the immunoreaction product resembled that described for GABA immunocytochemistry in previous reports (Somogyi et al., 1985; Gamrani et al., 1986) . It was diffuse in somata, dendrites, and nerve terminals, showing no precise relationship with the cytoplasmic organelles except for a binding of immunoreaction product to the external side of their membrane. Some GABA was detected within synaptic vesicles.
The lack of abundant vesicular staining by GABA antibodies has been discussed in detail in a previous report (Gamrani et al., 1986) . Biochemical investigations tend to demonstrate that GABA is contained in the terminals within an extravesicular pool (Mangan and Whittaker, 1966; De Belleroche and Bradford, 1977; Kuriyama, 1976) . However, a displacement and relocalization of the molecule during biochemical, as well as immunocytochemical, procedures cannot be ruled out. It is worth considering that synaptic vesicles are rarely stained by immunocytochemistry for small molecules such as dopamine (Onttniente et al., 1984; Kah et al., 1986) , serotonin (Maxwell et al., 1983) or some peptides (see Pickel, 1985) , which have been clearly demonstrated to be contained within synaptic vesicles. The nonvesicular staining may not reflect the absence of GABA within synaptic vesicles, but could result from either a relocalization of GABA during histochemical processing and/or a poor penetration of the antibodies through the vesicular membrane. The latter hypothesis is maintained if we consider that a general labeling of synaptic vesicles by anti-GABA antibodies is observed when the tissue is damaged (unpublished observations and Ottersen and Storm-Mathisen, 1984) . The GABA-immunolabeling of large granulated vesicles reported by Somogyi et al. (1985) and Ottersen and Storm-Mathisen (1984) was not observed in our material. GABA coexists with various neuroactive peptides in several regions of the brain (for a review, see Mugnaini and Oertel, 1985) . Concerning the septum, data are lacking. Seventeen peptides have been evidenced in this brain region (Palkovits and Brownstein, 1985) , among which substance P, enkephalins, somatostatin, and choa GABA-I bouton and an unlabeled terminal in contact with a GABA-I dendrite. Bar, 0.63 pm. G, Some GABA-I vesicles (arrows) are observed within the labeled terminals. Bar, 0.44 pm. lecystokinin are quantitatively the most representative. Doublelabeling studies are necessary in order to form a conclusion as to whether the large non-GABA-I granulated vesicles observed in GABA-I boutons correspond to storage sites of peptidergic cotransmitters.
GABAergic neurons in the brain display a great variability in size and shape. Originally described as consisting of inhibitory interneurons, the GABAergic brain population is now considered to include long-projection neurons (see Ribak et al., 198 1; Mugnaini and Oertel, 1985) . In the septum, on the basis of the morphological aspect of GAD- (Kohler and Chan-Palay, 1983; Panula et al., 1984) and GABA-(Onteniente et al., 1986) immunoreactive neurons, a dual population of GABAergic cells has been demonstrated. The GABA-I neurons of the lateral division are interneurons (De Feudis, 1984) , while the medial nucleus contains, in addition, a group of large GABAergic cells (Kohler and Chan-Palay, 1983; Panula et al., 1984; Onttniente et al., 1986) . The large GABA-I neurons of the medial septumdiagonal band of the Broca (dbB) complex were clearly distinguished from others under the electron microscope. No characteristic of their fine structure and synaptic organization could be observed in the smaller cells, except for a higher density of synaptic boutons on cell bodies of large size in the medial septum, which may correlate eventual functional differences.
Synaptic relationships of GABA-I elements Various means of GABAergic inhibition have been electrophysiologically demonstrated in the brain. The morphological evidence for 2 of these was observed in this study. Symmetrical junctions between GABA-I boutons and unlabeled elements were the most frequent, corresponding to postsynaptic inhibition. GABAergic boutons on GABAergic neurons were the second type of synaptic relationship observed, corresponding to disinhibition.
GABA-GABA interactions are frequent in the CNS (Ribak et al., 1979; Bolam et al., 1983; Oertel et al., 1984; Mugnaini, 1985) and were observed in the lateral and medial septum, which correlated with electrophysiological data demonstrating an inhibition of inhibitory septal interneurons (De France, 1976) . In addition to these 2 kinds of inhibition, axoaxonic contacts were observed between GABA-I and unlabeled terminals forming synapses with GABA-I cell bodies. This finding may reflect presynaptic inhibition. However, since symmetrical synapses lack clear, postsynaptic thickening, despite the presence of vesicles at the zone of contact, it could not be assessed that such contacts were synapses.
The lateral septal nuclei receive afferents from the hippocampus (Swanson and Cowan, 1979) , which contains numerous GABA-I cells (Ribak et al., 1978) . However, no evidence for a GABAergic projection from the hippocampus to the septum exists. GABA-I boutons observed on GABA-I neurons probably originate in the septum itself or in other subcortical structures.
The medial septal nucleus receives afferents from the neurons of the lateral nucleus, some of which are GABAergic and may participate in the inhibition of the 2 morphologically distinct GABAergic cell populations of this region. The large GABA-I neurons participate in the septohippocampal pathway (Kohler et al., 1984) . It has been electrophysiologically demonstrated that the septohippocampal neurons receive inhibitory inputs (McLennan and Miller, 1974; Dutar et al., 1985) , which are most probably mediated by GABA. The synaptic interactions observed between GABA-I cell bodies and GABA-I terminals in the medial septum-dbB complex well correlate this fact and may demonstrate a disinhibition of GABAergic septohippocampal neurons by GABAergic septal interneurons. Further studies would be necessary to determine whether this inhibition is mediated by local or extrinsic neurons, or is due to recurrent collaterals, as was suggested by De France (1976) .
Relationships with other neuronal systems The lateral septum contains most of the known neurotransmitters and neuroactive substances. A great number of peptides and amino acids (Ottersen and Storm-Mathisen, 1984) have been evidenced within cell bodies, while afferents include peptidergic fibers arising from the hypothalamic area (DeVries and Buijs, 1983; Poulain et al., 1984) , dopaminergic fibers from the ventrotegmental area (Lindvall and Stenevi, 1978; Moore, 1978; Simon et al., 1979) , serotoninergic fibers from the raphe nuclei (Azmitia and Segal, 1978; Kiihler et al., 1982) and noradrenergic fibers from the locus coeruleus (Swanson and Hartman, 1975; Moore, 1978) . Some ofthese projections (dopamine: Onteniente et al., 1984; enkephaline and substance P: Gall and Moore, 1984; serotonin: Kijhler et al., 1982; Gall and Moore, 1984 ) display a characteristic pericellular distribution that could correspond to the high density of unlabeled boutons observed on GABA-I cells.
Within the medial septum+lbB complex, the implication of GABA in the dopaminergic regulation of choline@ septohippocampal cells is well known (Cheney et al., 1978) . Interactions have also been shown between GABAergic fibers and gonadotrophin-releasing hormone (Jennes et al., 1983) . Double-labeling studies are now necessary to gain more information about the complex relationships between GABA and the various neurotransmitters contained within this brain region. et al. l GABA-lmmunoreactivity in the Septum of the Rat
